Development of a novel delivery system for mRNA COVID-19 vaccines

Key facts

Disease
COVID-19
Start & end year
2021
2023
Known Financial Commitments (USD)
$825,923.46
Funder
Swiss National Science Foundation (SNSF)
Principal Investigator
Steve Pascolo
Research Location
Switzerland
Lead Research Institution
N/A
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
Vaccine design and administration
Special Interest Tags
Innovation
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

mRNA vaccines have showcased their tremendous potential amidst the COVID-19 pandemic. In this project, we aim to maximize the potential of mRNA vaccines by developing a novel vaccine carrier system to improve their efficacy, stability, safety, and cost-effectiveness.